SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Photoelectron Corp. (PECX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Clayleas who wrote ()10/30/1998 9:00:00 PM
From: Fred Puppet  Read Replies (1) of 16
 
At this rate, losing $2 million per quarter, the company has only enough working capital to survive until next summer. Normally companies try to do additional equity financing at this point. That could spell trouble for the stock price. Add in some end of the year tax loss selling and it's probably better to sit this one out until the next earnings report.

An important factor will be whether or not the "first order" for a PRS400 System becomes a "first sale" this quarter to bring in some revenue. I have been told that it was actually given away free, in which case there will be no revenues.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News